30 years of research have proven the effectiveness of virtual reality.

A bar chart showing an exponential increase in the number of publications from 1995 to 2025, rising from approximately 0 to over 900.
Number of scientific publications listed on PubMed with the keywords “virtual reality” and “pain” or “anxiety”
Pain

Up to

83%

of reduction*

Anxiety

Up to

73%

of reduction*

Sedation

Up to

40%

of reduction in opioid use*

*compared to a control condition

The Foundations of Our Research Strategy

At Lumeen, we believe in the value of scientific evidence.Since our creation, we have been committed to clinical research and impact measurement around three main areas:

Co-construction

Our research is developed in close synergy with hospital and university teams, also relying on the expertise of caregivers present in our team, in order to anchor innovation in the reality of clinical and medico-social practices.

Integrity

Each study conducted with Lumeen respects the highest standards of methodological rigor and scientific independence, in order to produce reliable, credible and recognized results.

Sharing

By sharing our work and results, we aspire to actively contribute to the progress of research and to the emergence of new immersive and non-drug therapeutic approaches, at the service of patients' well-being.

Our clinical results

12

clinical studies carried out

15

usage studies

5

clinical studies in progress

clinical study
92%

tolerance and acceptance of the Lumeen device among elderly people cognitive disorders in care homes

33 patients

Study on the Tolerance of virtual reality care homes

clinical study

A Study on the Effects ofanxiety virtual reality to Manage pain anxiety virtual reality painful procedures

Significant reduction

pain anxiety treatment in the VR group compared to the control group

120 patients
clinical study

Study of the Efficacy of Lumeen in Reducinganxiety in Surgery

94,3%

Some patients are experiencing the benefits of virtual reality

94,4%

Healthcare professionals are satisfied with the device's effects on patients

106 patients
Customer Satisfaction Survey

Evaluation of the Clinical Benefits of Lumeen Relaxation Dialysis

57%

Some patients reported a significant reduction inanxiety the session

84%


ly increasing well-being

78%

to enhance the experience during the session

272 patients
Customer Satisfaction Survey

Number of patients who experienced pain during embryo transfer

Halved
45 female patients

Our impact measurement challenges

As a non-drug intervention

Environmental impact

Towards a more sustainable and responsible healthcare

Lumeen wants to contribute to medication sobriety and to the reduction of the carbon footprint associated with polluting anesthetics.

Anesthetic gases, such as desflurane, have a global warming power up to 2,500 times greater than CO₂, while some intravenous anesthetics can end up in water.

By integrating Lumeen as a complement or alternative to pharmacological products and medical gases, it is possible to reduce the use of substances with a high environmental impact and to contribute to a more eco-responsible hospital practice.

Medico-economic impact

Optimizing the patient journey and hospital resources

In many care pathways, virtual reality significantly reduces the use of medications, thus limiting their side effects. In some cases, it also reduces the need for medical equipment.

It also makes it possible to reduce the time spent in the post-interventional monitoring room, promoting faster patient turnover and better fluidity of care.
These combined effects can generate a positive return on investment for institutions and the healthcare system, while improving the patient experience.

Our ambition is to precisely measure these benefits over time in order to demonstrate that Lumeen can not only have a positive clinical and ecological impact, but also contribute to substantial savings for healthcare facilities.

Did you know ?

Virtual reality, recognized as a non-drug intervention (INM) by the Médéric Alzheimer Foundation

Non-drug interventions, recommended by the French Haute Autorité de Santé (HAS), contribute to the prevention of loss of autonomy.

The benefits of virtual reality have been demonstrated:
- Improvement of cognitive skills- Reduction in psychobehavioral disorders
- Improvement of social interactions and quality of life‍

Consult the guidebook Non-drug interventions and Alzheimer's disease: understanding, knowing, implementing 2024 edition from the Médéric Alzheimer Foundation to learn more.

A virtual reality headset virtual reality the Lumeeen logo placed on a surface, with blurry medicine boxes in the background.